Diagnostics Market Research
Explore your competitors and realise your potential in the Diagnostics market. Our reports include information on Testing, Companion Markets, Imaging and In Vitro Diagnostics.
Stay up-to-date with new products added to this category
first
previous
Title  | Date  | Price |
|---|---|---|
| Epstein-Barr Virus (EBV) NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| MSSA NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| MRSA NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Factor II NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Group B Streptococcus (GBS) NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Influenca A/B NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HLA Typing NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Human Metapneumovirus (hMPV) NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Neisseria Gonorrheae (NG) NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HSV 1 NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HPV Quantitative NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HSV 2 NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HPV Quantitative NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Group A Streptococcus (GAS) NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Fragile X NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HIV Genotyping NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HCV Genotyping NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Staphylococcus aureus NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Mycobacterium Tuberculosis Direct (MTD) NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HPV Genotyping NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Factor V Leiden NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HCV Qualitative NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HBV Viral Load NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HCV Genotyping NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HBV Ressistance NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Human Metapneumovirus (hMPV) NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Mycobacterium tuberculosis (MTB) NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| BK Virus NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Parainfluenza 1, 2, 3 NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HBV Quantitative NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HIV Genotyping NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Her2Neu NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Factor II NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Fragile X NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HSV 2 NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| VZV NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Her2Neu NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| MAC NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Enterovirus NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HIV Qualitative NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Clostridium Difficile (C.diff) NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Cystic Fibrosis, Mucoviscoidosis NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Clostridium Difficile (C.diff) NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Chlamydia Trachomatis (CT) NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Assessment of the Molecular Diagnostic Market for Adenovirus NA Tests in Germany | Apr 2009 | £355 |
| HIV Viral Load NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Group A Streptococcus (GAS) NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Influenca A/B NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Her2Neu NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| MAC NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HIV Viral Load NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HCV Viral Load NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Factor V Leiden NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HCV Viral Load NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HCV Genotyping NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HBV Viral Load NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HPV Genotyping NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HLA Typing NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| CMF Viral Load NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Group B Streptococcus (GBS) NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Medical Diagnostics Plimsoll Portfolio Analysis | Apr 2009 | £350 |
| Freedonia Focus on In Vitro Diagnostics | Mar 2009 | £310 |
| North American Selected Diagnostics Equipment Market | Mar 2009 | £4,510 |
| Strategic Analysis of Optical Imaging Technologies in U.S. Clinical Diagnostics and Drug Discovery Markets | Mar 2009 | £3,605 |
| The Top 100 Molecular Diagnostics Manufacturing Companies Worldwide | Mar 2009 | £620 |
| In Vitro Diagnostics US Industry Study with Forecasts for 2013 & 2018 | Mar 2009 | £2,970 |
| Who's Doing What in Molecular Diagnostics? Kalorama / Emmes Survey of US Laboratories | Feb 2009 | £3,005 |
| World Market for Molecular Diagnostics | Jan 2009 | £2,400 |
| Therapeutics and Diagnostics for Women's Disorders | Jan 2009 | £2,915 |
| Molecular Diagnostics A Dynamic and Rapidly Broadening Market Overview | Jan 2009 | £2,255 |
| World Market for Molecular Diagnostics, The | Jan 2009 | £2,400 |
| U.S. Molecular Diagnostics Markets for Emerging Infectious Disease Tests | Dec 2008 | £3,605 |
| Worldwide Market for in Vitro Diagnostic (Ivd) Tests 6th Edition [with 2009 Economy Preface] | Dec 2008 | £2,400 |
| Molecular Diagnostics: a primer on an emerging sector | Nov 2008 | £4,635 |
| HighGrowth Diagnostic Markets | Nov 2008 | £2,105 |
| Blood The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products | Nov 2008 | £2,400 |
| High-Growth Diagnostic Testing Markets | Nov 2008 | £2,105 |
| Glucose Testing Markets | Nov 2008 | £1,200 |
| DNA Probes-based Diagnostics | Oct 2008 | £2,075 |
| Cholesterol & Other Cardiovascular Testing | Oct 2008 | £2,375 |
| Genetic Testing | Oct 2008 | £2,375 |
| HIV/AIDS Testing | Oct 2008 | £2,375 |
| Monoclonal Antibody Based Products | Oct 2008 | £2,375 |
| Hemoglobin A1c Monitoring | Oct 2008 | £2,375 |
| Growth Factors (Blood And Tissue) | Oct 2008 | £2,375 |
| Blood Glucose Meters and Strips | Oct 2008 | £2,375 |
| Molecular Diagnostics Markets | Sep 2008 | £2,105 |
| Medical Devices And Diagnostics | Sep 2008 | £870 |
| European Patient Temperature Management Systems | Sep 2008 | £3,910 |
| Laboratory Automation | Sep 2008 | £570 |
| Women's Health Diagnostic Testing | Aug 2008 | £2,105 |
| 2008 Worldwide Diagnostic Imaging Centers Industry Report | Jul 2008 | £150 |
| European Diagnostic Cardiovascular Monitoring Equipment Markets | Jun 2008 | £3,605 |
| Indian Laboratory Analytical Instruments Markets | Jun 2008 | £3,605 |
| Western European IVD Markets | Jun 2008 | £3,910 |
| Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine) | Jun 2008 | £1,800 |
| Diabetes Diagnostics | May 2008 | £2,075 |
| Hematology Instruments and Reagents | May 2008 | £2,375 |
| Cardiac Marker Diagnostic Testing Markets | May 2008 | £2,075 |
Filter Results by
Industry Events
Advancing Biologics from the Lab to the Clinic
11 Jan 10 to 12 Jan 10
Brussels, Belgium
view summary >>
Best Practice in Phase IV Clinical & Observational Research
03 Dec 09 to 04 Dec 09
Prague, Czech Republic
view summary >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
